Authors:
Guermonprez, P
Khelef, N
Blouin, E
Rieu, P
Ricciardi-Castagnoli, P
Guiso, N
Ladant, D
Leclerc, C
Citation: P. Guermonprez et al., The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18), J EXP MED, 193(9), 2001, pp. 1035-1044
Citation: G. Karimova et al., Bordetella pertussis adenylate cyclase toxin as a tool to analyze molecular interactions in a bacterial two-hybrid system, INT J MED M, 290(4-5), 2000, pp. 441-445
Authors:
Guermonprez, P
Fayolle, C
Karimova, G
Ullmann, A
Leclerc, C
Ladant, D
Citation: P. Guermonprez et al., Bordetella pertussis adenylate cyclase toxin: A vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells, METH ENZYM, 326, 2000, pp. 527-542
Authors:
Dautin, N
Karimova, G
Ullmann, A
Ladant, D
Citation: N. Dautin et al., Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli, J BACT, 182(24), 2000, pp. 7060-7066
Authors:
Fayolle, C
Ladant, D
Karimova, G
Ullmann, A
Leclerc, C
Citation: C. Fayolle et al., Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope, J IMMUNOL, 162(7), 1999, pp. 4157-4162
Authors:
Guermonprez, P
Ladant, D
Karimova, G
Ullmann, A
Leclerc, C
Citation: P. Guermonprez et al., Direct delivery of the Bordetella pertussis adenylate cyclase toxin to theMHC class I antigen presentation pathway, J IMMUNOL, 162(4), 1999, pp. 1910-1916